New technological innovations revealed at ASHP 2017
Becton, Dickinson and Company (BDX), or BD, established itself as the leader in the medication management market with the acquisition of CareFusion in 2015. On December 4, 2017, BD showcased several technological innovations for the optimization of the medication management process at the ASHP (American Society of Health-System Pharmacists) 2017 Midyear Meeting.
The leading developers of medication management solutions in the market are McKesson (MCK), Cerner (CERN), and Allscripts Healthcare Solutions (MDRX). Investors keen on participating in the growth potential of BD while diversifying the risks specific to the company can consider investing in the (VTI), which invests ~0.18% of its total portfolio in BDX stock. Cerner, McKesson, and Allscripts Healthcare Solutions form approximately 0.08%, 0.12%, and 0.01%, respectively, of VTI’s total portfolio.
BD HealthSight platform
BD HealthSight platform for EMR (enterprise medication management) is the recent innovative product launch that offers better and more efficient connectivity, analytics, and expert services. The technology integration capabilities of the company, along with its ability to integrated with the EMR at the hospitals provide value to its customers, strengthening the company’s market position amid the changing dynamics in the healthcare industry, which is moving toward value-based care.
BD HealthSight Viewer, an integrated web-based pharmacy operations dashboard, offers single-view capabilities for the critical data from BD Alaris infusion system and BD Pyxis dispensing system, improving the medication management.
BD Pyxis ES latest software release
BD Pyxis ES system was updated with the latest software release recently. The new enhancements include bidirectional inventory level management, interoperability with both Epic and Cerner enhanced dispensing, bedside medication request raising abilities. The latest software release for BD Pyxis ES works well with BD HealthSight.
New enhancements to BD Pyxis IV Prep
BD’s portfolio of IV (intravenous) medications has been constantly expanding with the innovative set of new medications. Recently, the company made certain enhancements to its BD Pyxis IV prep medication. The new enhancements include more configuration options, and real-time error detection enabling better accuracy in IVs preparations and more efficient hospital operations.